Navigation Links
Sucking Out Clot Debris Helps Heart Attack Patients
Date:2/6/2008

Dutch study found vacuuming clogged vessels before angioplasty improved outcomes

WEDNESDAY, Feb. 6 (HealthDay News) -- Vacuuming out loose pieces of clots in blocked heart vessels improved the results of artery-opening angioplasty in a Dutch trial.

The technique, called thrombus aspiration, has been available for several years, said Dr. Felix Zijlstra, a professor of cardiology at the University of Groningen and senior author of the report in the Feb. 7 issue of the New England Journal of Medicine.

The trial included 1,071 persons who were assigned to get either conventional angioplasty or thrombus aspiration as part of their regimen. A major measure used by the Dutch researchers was blush grade, in which X-rays determine how well blood flow resumes to heart muscle after injury. A higher blush grade indicates better blood flow.

The lowest score, blush grade 0 to 1, was recorded for 26.3 percent of those getting conventional treatment and 17.1 percent of those who also had thrombus aspiration, the researchers reported. Thirty days after treatment, 5.2 percent of those with blush grades of 0 or 1 had died, compared to 1 percent of those with blush grades of 3.

Adverse affects such as second heart attacks occurred in 14.1 percent of those with the lowest blush grades, compared to 4.2 percent of those with the highest blush grades.

"In our practice, after we finished this trial, we adopted it [thrombus aspiration] for all patients, at least 80 to 90 percent of them," Zijlstra said.

When the trial results are publicized, "I think it will be adopted on a large scale very quickly," he said. The technique is easily learned, Zijlstra added: "I can teach it in an afternoon to every experienced cardiologist."

However, Dr. Gregg W. Stone, a professor of medicine at Columbia University and an expert in the field, had some cautionary words.

"There have been many prior trials, probably between 16 and 20," Stone said. "Everyone in the field has been interested for many years in the concept of removing thrombus. I, along with others, originated it and ran the first big trial."

Studies using two kinds of devices that actively break up clots and suck out the fragments have shown "no benefit and some harm," Stone said. The new study uses a more passive suction device, which smaller trials have shown gives results that are "mixed to slightly positive," he said.

"This trial is significant, because it is the largest study ever done," Stone said. "It pretty much showed what the other trials have shown. It showed trends in the right direction, although they were not statistically significant."

Because the study had some weaknesses, notably lacking a measure of the size of coronary muscle affected by the heart attacks, "I don't think it will have a major impact on how people practice," Stone said. "People who were on the fence may start using it in selected cases. But, unfortunately, it is not a definitive study."

More information

Learn about treatment of heart attacks from the American Heart Association.



SOURCES: Felix Zijlstra, M.D., Ph.D., professor, cardiology, University of Gronigen, Netherlands; Gregg W. Stone, M.D., professor, medicine, Columbia University, New York City; Feb. 7, 2008, New England Journal of Medicine


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
2. Direct Anesthetic Infusion Helps Colorectal Cancer Patients
3. Radiation and drug combo helps boost efficacy of lung cancer treatment
4. Childs Flu Shot Helps Whole Family
5. Microsoft Helps Developers of Clinical User Interfaces Improve Efficiency, Patient Safety With Free Toolkit
6. Generic prostate drug helps find high-risk cancers early
7. Tamoxifen Helps Treat Bipolar Disorder
8. Imaging Software Helps Track, Treat Injured Brains
9. GPS-like technology helps pinpoint best methods for moving injured players
10. New Website Helps Women Be Fit, Sexy and in Control!
11. Brain Defect Helps Drive Fragile X Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Sucking Out Clot Debris Helps Heart Attack Patients 
(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: